Domov › Srčno popuščanje › Texas › Dallas
Klinične študije za Srčno popuščanje v Dallas, TX
42 študij za Srčno popuščanje išče udeležence na lokacijah v Dallas in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
ELEVATE-HFpEF Clinical Study
Vključevanje udeležencev
- Dallas VA Medical Center, Dallas
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Vključevanje udeležencevFaza 3
- Research Site, Dallas
- Research Site, Dallas
- Research Site, Dallas
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Vključevanje udeležencevFaza 3
- Texas Health Research and Education Institute, Dallas
- Southwest Family Medicine Associates, Dallas
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Vključevanje udeležencevFaza 3
- Texas Health Research and Education Institute, Dallas
- Southwest Family Medicine Associates, Dallas
- University of Texas Southwestern Medical Center, Dallas
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Vključevanje udeležencevFaza 2
- University of Texas Southwestern Medical Center, Dallas
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Vključevanje udeležencev
- University of Texas Southwestern Medical Center, Dallas
- Parkland Health & Hospital System (PHHS), Dallas
- Baylor Scott and White - Health System, Dallas
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Vključevanje udeležencevFaza 3
- Research Site, Dallas
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Vključevanje udeležencevFaza 3
- Baylor University Medical Center, Dallas
- The University of Texas Southwestern Medical Center, Dallas
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Vključevanje udeležencev
- University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location, Dallas
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Vključevanje udeležencevFaza 3
- Cedar Health Research, LLC, Dallas
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Vključevanje udeležencevFaza 3
- Research Site, Dallas
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Vključevanje udeležencevFaza 3
- Dallas, TX Investigative Site 10042, Dallas
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Vključevanje udeležencev
- Baylor University Medical Center, part of Baylor Scott & White Health, Dallas
- UT southwestern Medical Center, Dallas
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Vključevanje udeležencevFaza 2
- Local Institution - 167, Dallas
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Vključevanje udeležencevFaza 2/3
- Children's Health-The Heart Center ( Site 0015), Dallas
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Vključevanje udeležencevFaza 2
- University of Texas Southwestern Medical Center, Dallas, Dallas
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Vključevanje udeležencevOpazovalna študija
- Dallas, Dallas
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Vključevanje udeležencevOpazovalna študija
- North Texas Cardiology Center, Dallas
- Baylor Scott & White Research Institute, Dallas
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Vključevanje udeležencevFaza 3
- Tenax Investigational Site, Dallas
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Vključevanje udeležencevFaza 3
- Renal Disease Research Institute, Dallas
- Texas Health Heart and Vascular Specialists, Dallas
- Southwest Family Medicine_Dallas, Dallas
- in še 1
Alleviant ALLAY-HF Study
Vključevanje udeležencev
- UT Southwestern, Dallas
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Vključevanje udeležencev
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
Vključevanje udeležencevOpazovalna študija
- Baylor University Medical Center, Dallas
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Vključevanje udeležencevFaza 2
- Children's Health Dallas, Dallas
Assessment of CCM in HF With Higher Ejection Fraction
Vključevanje udeležencev
- Baylor Scott and White Research Institute, Dallas
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Vključevanje udeležencevFaza 3
- Children's Medical Center Dallas - Cardiology, Dallas
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Vključevanje udeležencev
- Medical City Healthcare Dallas, Dallas
- Baylor Scott & White -Dallas, Dallas
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Vključevanje udeležencevFaza 3
- Children's Medical Center Dallas - Cardiology, Dallas
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Vključevanje udeležencev
- Baylor University Hospital, Dallas
Home-based Cardiac Rehabilitation in Heart Failure
Vključevanje udeležencevFaza 3
- University of Texas Southwestern Medical Center, Dallas
- Baylor Scott and White Health System, Dallas
IEEM-Heat and Heart Failure
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Institute for Exercise and Environmental Medicine - Texas Health Presbyterian Hospital Dallas, Dallas
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
Vključevanje udeležencev
- UT Southwestern Medical Center, Dallas
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Vključevanje udeležencevFaza 3
- University of Texas Southwestern, Dallas
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Vključevanje udeležencev
- University of Texas Southwestern Medical Center, Dallas
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
Vključevanje udeležencevFaza 2
- UT Southwestern Medical Center, Dallas
Cardiopulmonary Stress Testing (CPET) AlloSure Study
Vključevanje udeležencevOpazovalna študija
- Baylor Scott & White health research institute, Dallas
Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
Vključevanje udeležencevFaza 2
- Baylor University Medical Center, Dallas
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
Vključevanje udeležencevFaza 2/3
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Cardiogenic Shock Working Group Registry
Vključevanje udeležencevOpazovalna študija
- Baylor Scott & White Advanced Heart Failure Clinic, Dallas
Get With The Guidelines-Heart Failure Registry
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Amy Bennett, Dallas
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Vključevanje udeležencevOpazovalna študija
- UT Southwestern Medical Center, Dallas
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Vključevanje udeležencevFaza 1/2
- University of Texas Southwestern Medical Center, Dallas
Študije za Srčno popuščanje v drugih mestih
- New York City, NY51 študij
- Boston, MA44 študij
- Houston, TX36 študij
- Cleveland, OH33 študij
- Chicago, IL31 študij
- Philadelphia, PA31 študij
- San Francisco, CA29 študij
- St. Louis, MO26 študij
- Durham, NC26 študij
- Kansas City, MO25 študij
- Atlanta, GA25 študij
- Baltimore, MD24 študij
Druge študije v Dallas
- Rak dojke55 študij
- Nemalicelični pljučni rak52 študij
- Metastatski rak42 študij
- Rak (vse vrste)37 študij
- Rak prostate36 študij
- Kolorektalni rak33 študij
- Debelost30 študij
- Rak jajčnikov28 študij
- Rak mehurja27 študij
- Rak pljuč27 študij
- Rak endometrija24 študij
- Srčno-žilne bolezni23 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.